1-8 of 8
telomere
Close
Sort by
Journal Articles

Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita

Siddharth Shukla, Ho-Chang Jeong, Christopher M. Sturgeon, Roy Parker, Luis Francisco Zirnberger Batista
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2717–2722.
https://doi.org/10.1182/bloodadvances.2020001848
Published: 2020
Includes: Supplemental data
Journal Articles

Search for multiple myeloma risk factors using Mendelian randomization

Molly Went, Alex J. Cornish, Philip J. Law, Ben Kinnersley, Mark van Duin, Niels Weinhold, Asta Försti, Markus Hansson, Pieter Sonneveld, Hartmut Goldschmidt, Gareth J. Morgan, Kari Hemminki, Björn Nilsson, Martin Kaiser, Richard S. Houlston
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2172–2179.
https://doi.org/10.1182/bloodadvances.2020001502
Published: 2020
Includes: Supplemental data
Journal Articles

Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia

Anne-Sophie Bouillon, Monica S. Ventura Ferreira, Shady Adnan Awad, Johan Richter, Andreas Hochhaus, Volker Kunzmann, Jolanta Dengler, Jeroen Janssen, Gert Ossenkoppele, Peter E. Westerweel, Peter A. W. te Boekhorst, Francois-Xavier Mahon, Henrik Hjorth-Hansen, Susanne Isfort, Thoas Fioretos, Sebastian Hummel, Mirle Schemionek, Stefan Wilop, Steffen Koschmieder, Susanne Saußele, Satu Mustjoki, Fabian Beier, Tim H. Brümmendorf
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1572–1579.
https://doi.org/10.1182/bloodadvances.2018017772
Published: 2018
Includes: Supplemental data
Journal Articles

Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita

Clinical Trials & Observations
Payal P. Khincha, Alison A. Bertuch, Shahinaz M. Gadalla, Neelam Giri, Blanche P. Alter, Sharon A. Savage
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1243–1249.
https://doi.org/10.1182/bloodadvances.2018016964
Published: 2018
Journal Articles

Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms

Judith C. W. Marsh, Fernanda Gutierrez-Rodrigues, James Cooper, Jie Jiang, Shreyans Gandhi, Sachiko Kajigaya, Xingmin Feng, Maria del Pilar F. Ibanez, Flávia S. Donaires, João P. Lopes da Silva, Zejuan Li, Soma Das, Maria Ibanez, Alexander E. Smith, Nicholas Lea, Steven Best, Robin Ireland, Austin G. Kulasekararaj, Donal P. McLornan, Anthony Pagliuca, Isabelle Callebaut, Neal S. Young, Rodrigo T. Calado, Danielle M. Townsley, Ghulam J Mufti
Journal: Blood Advances
Blood Adv (2018) 2 (1): 36–48.
https://doi.org/10.1182/bloodadvances.2017008110
Published: 2018
Includes: Supplemental data
Journal Articles

Maintenance of telomere length in AML

Peter M. Lansdorp
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2467–2472.
https://doi.org/10.1182/bloodadvances.2017012112
Published: 2017
Journal Articles

Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT

Clinical Trials & Observations
Aliénor Xhaard, Renato Cunha, Marc Busson, Marie Robin, Nathalie Dhedin, Tereza Coman, Aurélie Cabannes-Hamy, Flore Sicre de Fontbrune, David Michonneau, Gérard Socié, Rodrigo T. Calado, Régis Peffault de Latour
Journal: Blood Advances
Blood Adv (2017) 1 (18): 1409–1413.
https://doi.org/10.1182/bloodadvances.2017008094
Published: 2017
Journal Articles

Extended clinical and genetic spectrum associated with biallelic RTEL1 mutations

Fabien Touzot, Laetitia Kermasson, Laurent Jullien, Despina Moshous, Christelle Ménard, Aydan Ikincioğullari, Figen Doğu, Sinan Sari, Vannina Giacobbi-Milet, Amos Etzioni, Jean Soulier, Arturo Londono-Vallejo, Alain Fischer, Isabelle Callebaut, Jean-Pierre de Villartay, Thierry Leblanc, Caroline Kannengiesser, Patrick Revy
Journal: Blood Advances
Blood Adv (2016) 1 (1): 36–46.
https://doi.org/10.1182/bloodadvances.2016001313
Published: 2016
Includes: Supplemental data